Given the central inflammatory role that macrophages play in cardiovascular disease, we hypothesised that the opposing effects of IL-4 and IL-13 may be via their differential modulation of M2 macrophage function, specifically the release of ROS. This evidence concerns the gene IL13 and cardiovascular disorder.